Key result
Review outlines cardiac f-channel mechanisms and therapeutic implications of I(f) inhibitors like ivabradine in CVD.
Why the study?
Currently available heart rate-lowering drugs have multiple cardiovascular effects, some undesired, motivating interest in agents exclusively targeting sinus node pacemaker activity.
This review outlines the basic properties of cardiac f-channels and the therapeutic potential of I(f)-current inhibitors like ivabradine for heart rate lowering in cardiovascular disease.
Answers are grounded in this paper and cite their sources.
May support selective heart-rate lowering without off-target effects; leaves open whether dedicated trials will confirm outcome benefit.
Several studies have demonstrated that resting heart rate is an important correlate of cardiovascular and all-cause mortality and that the mortality benefit of some cardiovascular drugs seems to be related in part to their heart rate-lowering effects. Since the currently available classes of drugs with heart-rate lowering effect (e.g. beta-blockers and calcium channel antagonists) also exert multiple structural and functional actions on the cardiovascular system, which may be in some cases undesired, the introduction of a new class of agents exclusively affecting the pacemaker activity of the sinus node is of particular interest. The first molecule of this class - sinus node modulators or I(f)-current inhibitors - to reach clinical application is ivabradine. Cardiac pacemaker cells generate a spontaneous slow diastolic depolarisation that drives the membrane voltage away from a hyperpolarised level towards the threshold level for initiating a subsequent action potential, generating rhythmic action potentials that propagate through the heart and trigger myocardial contraction. The I(f) current is an inward ionic current that determines the slope of diastolic depolarisation, which in turn controls the heart beating rate. Extensive work has amply demonstrated its involvement in the generation of spontaneous activity. The molecular basis of the generation of the pacemaker current was landmarked by the cloning of hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels, which constitute the structural units of the f-channels. This review addresses the major basic properties of cardiac f-channels, with a focus on the mode of action of I(f)-current inhibitors and outlines the therapeutic implications of the existing research data.
No takes yet. Share an insight, caveat, or question.
Dilaveris et al. (2006) conducted a review in Cardiovascular Disease. I(f)-current inhibitors (ivabradine) was evaluated. This review outlines the basic properties of cardiac f-channels and the mode of action and therapeutic implications of I(f)-current inhibitors such as ivabradine in cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: